NCT00846482View on ClinicalTrials.gov

Exploratory Study Of The ERCC-1 Gene

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Colon CancerRectal Cancer
Interventions
DRUG

Oxaliplatin

Oxaliplatin will be administered once every 2 or 3 weeks

Trial Locations (2)

10461

Montefiore Medical Center - Weiler Campus, The Bronx

10467

Montefiore Medical Center - Moses Campus, The Bronx

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Albert Einstein College of Medicine

OTHER

NCT00846482 - Exploratory Study Of The ERCC-1 Gene | Biotech Hunter | Biotech Hunter